Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
2.
SAGE Open Med Case Rep ; 10: 2050313X221085760, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35341103

RESUMO

Myelodysplasia cutis is a relatively new described entity that is characterized by cutaneous plaques and nodules representing dermal infiltration of myeloid immature non-blastic cells. It can be related to myelodysplastic syndromes or myeloproliferative disorders. It has distinct clinical and histopathological features in comparison with leukemia cutis. We report an unusual case of late myelodysplasia cutis in a male patient with essential thrombocythemia. It is only the second case reported to be related to this myeloproliferative disorder.

3.
J Cutan Med Surg ; 22(3): 347-348, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29373923

RESUMO

Cutaneous larva migrans (CLM) is a zoonotic helminthiasis frequently imported to Canada by travellers to beach destinations in the tropics. The preferred treatment is oral ivermectin. We present a case of CLM acquired within the province of Quebec, a first in our provincial health records. Our case also puts forward the use of topical ivermectin as a possibly effective CLM treatment approach as our patient was successfully treated with 1 month of an ivermectin 1% cream applied locally twice daily.


Assuntos
Antiparasitários/uso terapêutico , Ivermectina/uso terapêutico , Larva Migrans/tratamento farmacológico , Feminino , Humanos , Larva Migrans/patologia , Pessoa de Meia-Idade , Quebeque
4.
J Cutan Med Surg ; 21(3): 261-262, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28300438

RESUMO

BACKGROUND: Oestrogen dermatitis is a rare disorder characterised by cyclical eruptions in association with a woman's menstrual cycle. METHODS: A 43-year-old woman with an 8-year history of cyclical inguinal dermatitis, with a negative patch test, was tested with intradermal progesterone and oestrogen. RESULTS: Intradermal testing was positive for oestrogen only. CONCLUSION: In a female patient with cyclical dermatitis, it is important to consider oestrogen or progesterone dermatitis in the differential diagnosis.


Assuntos
Doenças Autoimunes , Dermatite , Estrogênios/imunologia , Progesterona/efeitos adversos , Adulto , Feminino , Humanos , Ciclo Menstrual , Testes do Emplastro
5.
J Cutan Med Surg ; 21(3): 267-269, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28300446

RESUMO

Juvenile xanthogranuloma (JXG) is the most frequent form of non-Langerhans cell histiocytosis. We present a case of giant congenital JXG in a 7-week-old boy, who had a firm and incompressible lesion, measuring 3 × 4 cm in diameter, on his right flank. The clinical appearance of the lesion and the ultrasound results suggested a vascular tumor, such as a hemangioma. Histology confirmed a JXG, although there was an absence of Touton cells, which are usually pathognomonic of JXG. In light of these findings, it would be important to include JXG in the differential diagnosis of congenital tumours, particularly vascular lesions.


Assuntos
Xantogranuloma Juvenil , Humanos , Imuno-Histoquímica , Lactente , Masculino , Ultrassonografia
6.
J Cutan Med Surg ; 18(1): 69-71, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24377479

RESUMO

BACKGROUND: Eosinophilic fasciitis is a rare sclerosing syndrome with a poorly understood etiology. OBJECTIVE: We report a case of eosinophilic fasciitis in a 40-year-old man undergoing treatment with natalizumab for multiple sclerosis. Natalizumab is a selective adhesion molecule inhibitor that prevents interaction of leukocytes with endothelial cells. Peripheral blood eosinophilia has been described under treatment with natalizumab, but we herein report the first case to our knowledge of eosinophilic fasciitis as a possible complication of this medication.


Assuntos
Anticorpos Monoclonais Humanizados/efeitos adversos , Eosinofilia/induzido quimicamente , Fasciite/induzido quimicamente , Esclerose Múltipla/tratamento farmacológico , Adulto , Anticorpos Monoclonais Humanizados/uso terapêutico , Eosinofilia/diagnóstico , Eosinofilia/tratamento farmacológico , Eosinofilia/patologia , Fasciite/diagnóstico , Fasciite/tratamento farmacológico , Fasciite/patologia , Humanos , Hidroxicloroquina/uso terapêutico , Masculino , Natalizumab
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...